The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.
Blood pressure from mid- to late life and risk of incident dementia
Open accessAbstract
OBJECTIVE: To determine the association between blood pressure during midlife (40-64 years) to late life (≥65 years) and risk of incident dementia. METHODS: This study included 1,440 (758 women, mean age 69 ± 6 years) Framingham Offspring participants who were free of dementia and attended 5 consecutive examinations at 4-year intervals starting at midlife (1983-1987, mean age 55 years) until late life (1998-2001, mean 69 years) and subsequently were followed up for incident dementia (mean 8 years). We determined the effect of midlife hypertension (≥140/90 mm Hg), late life hypertension, lower late life blood pressure (<100/70 mm Hg), persistence of hypertension during mid- to late life, and steep decline in blood pressure from mid- to late life over an 18-year exposure period. RESULTS: During the follow-up period, 107 participants (71 women) developed dementia. Using multivariable Cox proportional hazards models, we found that midlife systolic hypertension (hazard ratio [HR] 1.57, 95% confidence interval [CI] 1.05-2.35) and persistence of systolic hypertension into late life (HR 1.96, 95% CI 1.25-3.09) were associated with an elevated risk of incident dementia. However, in individuals with low to normal blood pressure (≤140/90 mm Hg) at midlife, a steep decline in systolic blood pressure during mid- to late life was also associated with a >2-fold increase in dementia risk (HR 2.40, 95% CI 1.39-4.15). CONCLUSIONS: Elevated blood pressure during midlife, persistence of elevated blood pressure into late life, and, among nonhypertensives, a steep decline in blood pressure during mid- to late life were associated with an increased dementia risk in a community-based cohort. Our data highlight the potential sustained cognitive benefits of lower blood pressures in midlife but also suggest that declining blood pressure in older adults with prehypertension or normotension, but not in those with hypertension, may be a risk marker for dementia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Life course is important when considering risk, for example, obesity and hypertension in midlife predict future dementia, but both weight and blood pressure usually fall in later life in those with or developing dementia,9 so lower weight and blood pressure in later life might signify illness, not an absence of risk.11, 12, 13, 14”
From Dementia prevention, intervention, and care: 2020 report of the Lancet Commission (2020) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the Framingham Offspring cohort comprising 1440 people, elevated systolic blood pressure (≥140 mm Hg in midlife; mean age 55 years) was associated with an increased risk of developing dementia (HR 1·6, 95% CI 1·1–2·4) over an 18 year follow-up period.”
From Dementia prevention, intervention, and care: 2020 report of the Lancet Commission (2020) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Of note, blood pressure declines in later life and this decline is associated with and, potentially caused by, dementia development (HR 2·4, 95% CI 1·4–4·2).”
From Dementia prevention, intervention, and care: 2020 report of the Lancet Commission (2020) · cites this paper as [12]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In this study risk increased further if hypertension persisted into later life (mean age 69 years; HR 2·0, 95% CI 1·3–3·1).”
From Dementia prevention, intervention, and care: 2020 report of the Lancet Commission (2020) · cites this paper as [12]
The cited source says what the claim attributes to it.
In the citing paper
“Persistent midlife hypertension is associated with increased risk of a late life dementia.”
From Dementia prevention, intervention, and care: 2020 report of the Lancet Commission (2020) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
Hu, R. J. (2003) · Elsevier eBooks · doi:10.1016/b0-12-226870-9/01070-4 · Cited by 9,168
The global prevalence of dementia: a systematic review and metaanalysis.
Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C. P. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.11.007 · Cited by 4,941
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Self-citation15-year longitudinal study of blood pressure and dementia
Skoog, I., Nilsson, L., Persson, G., Lernfelt, B., Landahl, S., Palmertz, B., Andreasson, L.-A., Odén, A., & Svanborg, A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90608-x · Cited by 1,726
Forette, F., Seux, M.-L., Staessen, J. A., Thijs, L., Birkenhäger, W. H., Babarskiene, M.-R., Babeanu, S., Bossini, A., Gil-Extremera, B., Girerd, X., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03086-4 · Cited by 1,441
Midlife cardiovascular risk factors and risk of dementia in late life
Whitmer, R. A., Sidney, S., Selby, J., Johnston, S. C., & Yaffe, K. (2005) · Neurology · doi:10.1212/01.wnl.0000149519.47454.f2 · Cited by 1,238
Midlife blood pressure and dementia: the Honolulu–Asia aging study☆
Launer, L. J., Ross, G. W., Petrovitch, H., Masaki, K., Foley, D., White, L. R., & Havlik, R. J. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00096-8 · Cited by 1,008
The framingham offspring study. Design and preliminary data
Feinleib, M., Kannel, W. B., Garrison, R. J., McNamara, P. M., & Castelli, W. P. (1975) · Preventive Medicine · doi:10.1016/0091-7435(75)90037-7 · Cited by 926
Cited by
Sorted by citations
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30367-6 · Cited by 10,430
“12,13,77”
Retracted2024 ESC Guidelines for the management of elevated blood pressure and hypertension
McEvoy, J. W., McCarthy, C. P., Bruno, R. M., Brouwers, S., Canavan, M. D., Ceconi, C., Christodorescu, R. M., Daskalopoulou, S. S., Ferro, C. J., Gerdts, E., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae178 · Cited by 2,298
The Epidemiology of Alzheimer's Disease Modifiable Risk Factors and Prevention
Zhang, X.-X., Tian, Y., Wang, Z.-T., Ma, Y.-H., Tan, L., & Yu, J.-T. (2021) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2021.15 · Cited by 789
Neurovascular and Cognitive Dysfunction in Hypertension
Iadecola, C., & Gottesman, R. F. (2019) · Circulation Research · doi:10.1161/circresaha.118.313260 · Cited by 530
Yin, F. (2023) · The FEBS Journal · doi:10.1111/febs.16344 · Cited by 441
Epidemiology of Vascular Dementia
Wolters, F. J., & Ikram, M. A. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.311908 · Cited by 445
Hypertension, Neurovascular Dysfunction, and Cognitive Impairment
Santisteban, M. M., Iadecola, C., & Carnevale, D. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.18085 · Cited by 317
Lane, C. A., Barnes, J., Nicholas, J. M., Sudre, C. H., Cash, D. M., Parker, T. D., Malone, I. B., Lu, K., James, S.-N., Keshavan, A., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30228-5 · Cited by 247
Zloković, B. V., Gottesman, R. F., Bernstein, K. E., Seshadri, S. S., McKee, A. C., Snyder, H. M., Greenberg, S. M., Yaffe, K. S., Schaffer, C. B., Yuan, C., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12157 · Cited by 252
Self-citationHypertension management in patients with cardiovascular comorbidities
Lauder, L., Mahfoud, F., Azizi, M., Bhatt, D. L., Ewen, S., Kario, K., Parati, G., Rossignol, P., Schlaich, M. P., Teo, K. K., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac395 · Cited by 232
Impaired insulin signalling and allostatic load in Alzheimer disease
Felice, F. G. D., Gonçalves, R. A., & Ferreira, S. T. (2022) · Nature reviews. Neuroscience · doi:10.1038/s41583-022-00558-9 · Cited by 183
Midlife Hypertension and Alzheimer’s Disease: A Systematic Review and Meta-Analysis
Lennon, M. J., Makkar, S. R., Crawford, J. D., & Sachdev, P. S. (2019) · Journal of Alzheimer’s Disease · doi:10.3233/jad-190474 · Cited by 190
Vascular contributions to Alzheimer's disease
Eisenmenger, L. B., Peret, A., Famakin, B. M., Spahic, A., Roberts, G. S., Bockholt, J. H., Johnson, K. M., & Paulsen, J. S. (2022) · Translational research · doi:10.1016/j.trsl.2022.12.003 · Cited by 183
Promoting Successful Cognitive Aging: A Ten-Year Update
Krivanek, T. J., Gale, S. A., McFeeley, B. M., Nicastri, C. M., & Daffner, K. R. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201462 · Cited by 189
Malik, R., Georgakis, M. K., Neitzel, J., Rannikmäe, K., Ewers, M., Seshadri, S. S., Sudlow, C. L. M., & Dichgans, M. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12320 · Cited by 172
Self-citationHypertension and Cognitive Impairment: A Review of Mechanisms and Key Concepts
Canavan, M. D., & O'Donnell, M. J. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.821135 · Cited by 180
Chinese Guidelines for the Prevention and Treatment of Hypertension (2024 revision)
Wang, J. (2025) · 老年心脏病学杂志：英文版 · doi:10.26599/1671-5411.2025.01.008 · Cited by 170
Is Alzheimer’s Disease Risk Modifiable?
Serrano‐Pozo, A., & Growdon, J. H. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad181028 · Cited by 169
Hypertension, Neurodegeneration, and Cognitive Decline
Pacholko, A. G., & Iadecola, C. (2024) · Hypertension · doi:10.1161/hypertensionaha.123.21356 · Cited by 170
Physical exercise, cognition, and brain health in aging
Silva, N. C. B. S., Barha, C. K., Erickson, K. I., Kramer, A. F., & Liu-Ambrose, T. Y. L. (2024) · Trends in Neurosciences · doi:10.1016/j.tins.2024.04.004 · Cited by 130
A Primary Care Agenda for Brain Health: A Scientific Statement From the American Heart Association
Lazar, R. M., Howard, V. J., Kernan, W. N., Aparicio, H. J., Levine, D. A., Viera, A. J., Jordan, L. C., Nyenhuis, D. L., Possin, K. L., Sorond, F. A., et al. (2021) · Stroke · doi:10.1161/str.0000000000000367 · Cited by 109
Associations Between Vascular Risk Across Adulthood and Brain Pathology in Late Life
Lane, C., Barnes, J., Nicholas, J. M., Sudre, C. H., Cash, D. M., Malone, I. B., Parker, T. D., Keshavan, A., Buchanan, S. M., Keuss, S. E., et al. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.3774 · Cited by 106
Modifiable Risk Factors in Alzheimer Disease and Related Dementias: A Review
Litke, R. R., Garcharna, L. C., Jiwani, S., & Neugroschl, J. A. (2021) · Clinical Therapeutics · doi:10.1016/j.clinthera.2021.05.006 · Cited by 118
Wagner, M., Helmer, C., Tzourio, C., Berr, C., Proust‐Lima, C., & Samieri, C. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.2004 · Cited by 93
Roles of vascular risk factors in the pathogenesis of dementia
Takeda, S., Rakugi, H., & Morishita, R. (2019) · Hypertension Research · doi:10.1038/s41440-019-0357-9 · Cited by 94
Vascular dementia: From pathobiology to emerging perspectives
Morgan, A. E., & Auley, M. T. M. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102278 · Cited by 102
Blood Pressure Levels and Risks of Dementia: a Nationwide Study of 4.5 Million People
Lee, C. J., Lee, J.-Y., Han, K., Kim, D. H., Cho, H., Kim, K. J., Kang, E. S., Cha, B.-S., Lee, Y., & Park, S. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.17283 · Cited by 84
Hypertension and Diagnosis of Parkinson’s Disease: A Meta-Analysis of Cohort Studies
Hou, L., Li, Q., Jiang, L., Qiu, H., Geng, C., Hong, J., Li, H., & Wang, Q. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00162 · Cited by 80
Mohan, D., on behalf of DePEC team, Yap, K. H., Reidpath, D. D., Soh, Y. C., McGrattan, A., Stephan, B. C. M., Robinson, L. A., Chaiyakunapruk, N., & Siervo, M. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191339 · Cited by 78
Detection of dementia on voice recordings using deep learning: a Framingham Heart Study
Xue, C., Karjadi, C., Paschalidis, I. C., Au, R., & Kolachalama, V. B. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00888-3 · Cited by 83
Amini, S., Hao, B., Zhang, L., Song, M., Gupta, A., Karjadi, C., Kolachalama, V. B., Au, R., & Paschalidis, I. C. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.12721 · Cited by 76
Variation in blood pressure and long-term risk of dementia: A population-based cohort study
Ma, Y., Wolters, F. J., Chibnik, L. B., Licher, S., Ikram, M. A., Albert Hofman, D., & Ikram, M. K. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002933 · Cited by 77
Legault, J., Thompson, C., Martineau‐Dussault, M., André, C., Baril, A., Villar, G. M., Carrier, J., & Gosselin, N. (2021) · Brain Sciences · doi:10.3390/brainsci11060706 · Cited by 76
McGrath, E. R., Himali, J. J., Levy, D. A., Conner, S. C., DeCarli, C. S., Pase, M. P., Ninomiya, T., Ohara, T., Courchesne, P. L., Satizábal, C. L., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014659 · Cited by 60
Self-citationMetabolic Syndrome, Cognitive Impairment and the Role of Diet: A Narrative Review
Kouvari, M., D'Cunha, N. M., Travica, N., Sergi, D., Zec, M. M., Marx, W., & Naumovski, N. (2022) · Nutrients · doi:10.3390/nu14020333 · Cited by 74
Blood pressure and the brain: the neurology of hypertension
Kelly, D., & Rothwell, P. M. (2019) · Practical Neurology · doi:10.1136/practneurol-2019-002269 · Cited by 65
Disentangling the Relationship Between Chronic Kidney Disease and Cognitive Disorders
Kelly, D., & Rothwell, P. M. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.830064 · Cited by 70
McGrath, E. R., Beiser, A., O’Donnell, A., Himali, J. J., Pase, M. P., Satizábal, C. L., & Seshadri, S. S. (2022) · Neurology · doi:10.1212/wnl.0000000000200521 · Cited by 65
Self-citationMid to Late Life Hypertension Trends and Cerebral Small Vessel Disease in the Framingham Heart Study
Petrea, R. E., O’Donnell, A., Beiser, A., Habes, M., Aparicio, H. J., DeCarli, C. S., Seshadri, S. S., & Romero, J. R. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15073 · Cited by 59
Self-citationGlodzik, L., Rusinek, H., Tsui, W., Pirraglia, E., Kim, H.-J., Deshpande, A., Li, Y., Storey, P., Randall, C., Chen, J., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11233 · Cited by 61
Heart health meets cognitive health: evidence on the role of blood pressure
Palta, P., Albert, M., & Gottesman, R. F. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00248-9 · Cited by 56
Blood Pressure Control and Dementia Risk in Midlife Patients With Atrial Fibrillation
Kim, D., Yang, P., Jang, E., Yu, H. T., Kim, T., Uhm, J., Kim, J., Sung, J., Pak, H., Lee, M., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.119.14388 · Cited by 61
Chuang, S., Lo, Y.-L., Wu, S.-Y., Wang, P., & Pan, W. (2019) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2018.10.017 · Cited by 58
Li, J., Liu, C., Ang, T. F. A., & Au, R. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12839 · Cited by 52
Risk Factors, Lifestyle Behaviors, and Vascular Brain Health
Gottesman, R. F., & Seshadri, S. S. (2022) · Stroke · doi:10.1161/strokeaha.121.032610 · Cited by 53
Self-citationLupton, M. K., Robinson, G. A., Adam, R. J., Rose, S., Byrne, G. J., Salvado, O., Pachana, N. A., Almeida, O. P., McAloney, K., Gordon, S. D., et al. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102527 · Cited by 49
Hypertension and Alzheimer's disease: is the picture any clearer?
Lennon, M. J., Koncz, R., & Sachdev, P. S. (2020) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000684 · Cited by 53
Liu, L., Hayden, K. M., May, N. S., Haring, B., Liu, Z., Henderson, V. W., Chen, J., Gracely, E. J., Wassertheil-Smoller, S. W., & Rapp, S. R. (2022) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(21)00283-x · Cited by 51
Circulating fibroblast growth factor 23 levels and incident dementia: The Framingham heart study
McGrath, E. R., Himali, J. J., Levy, D. A., Conner, S. C., Pase, M. P., Abraham, C. R., Courchesne, P. L., Satizábal, C. L., Vasan, R. S., Beiser, A., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213321 · Cited by 50
Self-citationCirculating ceramide ratios and risk of vascular brain aging and dementia
McGrath, E. R., Himali, J. J., Xanthakis, V., Duncan, M. S., Schaffer, J. E., Ory, D. S., Peterson, L. R., DeCarli, C. S., Pase, M. P., Satizábal, C. L., et al. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.50973 · Cited by 45
Self-citationHypertension-related risk for dementia: A summary review with future directions
Daugherty, A. M. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.03.002 · Cited by 49
Tau Mediates Synergistic Influence of Vascular Risk and Aβ on Cognitive Decline
Yau, W. W., Shirzadi, Z., Yang, H., Ikoba, A. P., Rabin, J. S., Properzi, M. J., Kirn, D. R., Schultz, A. P., Rentz, D. M., Johnson, K. A., et al. (2022) · Annals of Neurology · doi:10.1002/ana.26460 · Cited by 45
Early-but Not Late-Onset Hypertension Is Related to Midlife Cognitive Function
Suvila, K., Lima, J. A. C., Yano, Y., Tan, Z. S., Cheng, S. C., & Niiranen, T. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.16556 · Cited by 42
Burning Fog: Cognitive Impairment in Burning Mouth Syndrome
Canfora, F., Calabria, E., Cuocolo, R., Ugga, L., Buono, G., Marenzi, G., Gasparro, R., Pecoraro, G., Aria, M., D’Aniello, L., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.727417 · Cited by 48
Drake, J., Initiative, A. D. N., Chambers, A. B., Ott, B. R., & Daiello, L. A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200759 · Cited by 41
Lamballais, S., Sajjad, A., Leening, M. J. G., Gaillard, R., Franco, O. H., Mattace-Raso, F. U. S., Jaddoe, V. W. V., Roza, S. J., Tiemeier, H. W., & Ikram, M. A. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009847 · Cited by 44
Jeon, S. Y., Byun, M. S., Yi, D., Lee, J. H., Choe, Y. M., Ko, K., Sohn, B. K., Choi, H. J., Lee, J., & Lee, D. Y. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.11.001 · Cited by 42
Beta-blocker therapy and risk of vascular dementia: A population-based prospective study
Holm, H., Ricci, F., Martino, G. D., Bachus, E., Nilsson, E. D., Ballerini, P., Melander, O., Hansson, O., Nägga, K., Magnusson, M., et al. (2020) · Vascular Pharmacology · doi:10.1016/j.vph.2020.106649 · Cited by 42
Jiang, C., Li, S., Wang, Y., Lai, Y., Bai, Y., Zhao, M., He, L., Kong, Y., Guo, X., Li, S., et al. (2023) · Hypertension · doi:10.1161/hypertensionaha.122.20112 · Cited by 39
Villoz, F., Filippini, T., Ortega, N., Kopp‐Heim, D., Voortman, T., Blum, M. R., Giovane, C. D., Vinceti, M., Rodondi, N., & Chocano-Bedoya, P. O. (2023) · Advances in Nutrition · doi:10.1016/j.advnut.2023.100160 · Cited by 41
Amier, R. P., Marcks, N., Hooghiemstra, A. M., Nijveldt, R., van Buchem, M. A., Roos, A., Biessels, G. J., Kappelle, L. J., van Oostenbrugge, R. J., van der Geest, R. J., et al. (2020) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.06.040 · Cited by 39
Hypertension, a dementia polygenic risk score, APOE genotype, and incident dementia
Littlejohns, T. J., Collister, J. A., Liu, X., Clifton, L., Tapela, N. M., & Hunter, D. J. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12680 · Cited by 38
Visit-to-Visit Blood Pressure Variability and Longitudinal Tau Accumulation in Older Adults
Sible, I. J., Nation, D. A., Weiner, M. W., Aisen, P. S. S., Petersen, R. C., Jack, C. R., Jagust, W. J., Trojanowki, J. Q., Toga, A. W., Beckett, L., et al. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.18479 · Cited by 38
Bransby, L., Rosenich, E., Maruff, P. T., & Lim, Y. Y. (2023) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2023.119 · Cited by 37
Blood pressure and the brain: the conundrum of hypertension and dementia
Gottesman, R. F., Egle, M. S., Groechel, R. C., & Mughal, A. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvaf010 · Cited by 43
Associations between vascular risk factors and subsequent Alzheimer’s disease in older adults
Lee, H., Kim, K., Lee, Y. C., Kim, S., Won, H., Yu, T. Y., Lee, E. M., Kang, J. M., Lewis, M., Kim, D. K., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00690-7 · Cited by 39
Associations of hypertension burden on subsequent dementia: a population-based cohort study
Jung, H., Yang, P., Kim, D., Jang, E., Yu, H. T., Kim, T., Sung, J., Pak, H., Lee, M., Lip, G. Y. H., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-91923-8 · Cited by 35
Dynamic functional connectivity patterns associated with dementia risk
Dautricourt, S., Gonneaud, J., Landeau, B., Calhoun, V. D., de Florès, R., Poisnel, G., Bougacha, S., Ourry, V., Touron, E., Kuhn, E., et al. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01006-7 · Cited by 41
Kelly, D., Pinheiro, A., Koini, M., Anderson, C. D., Aparicio, H. J., Hofer, E., Kern, D., Blacker, D., DeCarli, C. S., Hwang, S., et al. (2024) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfae079 · Cited by 35
Self-citationRosenberg, A., Solomon, A., Jelić, V., Hagman, G., Bogdanović, N., & Kivipelto, M. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0557-1 · Cited by 34
Incidence of dementia after age 90 in a multiracial cohort
Gilsanz, P., Corrada, M. M., Kawas, C. H., Mayeda, E. R., Glymour, M. M., Quesenberry, C. P., Lee, C., & Whitmer, R. A. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.12.006 · Cited by 34
Pathogenetic Mechanisms of Hypertension–Brain-Induced Complications: Focus on Molecular Mediators
Chiara, T. D., Cuore, A. D., Daidone, M., Scaglione, S., Norrito, R. L., Puleo, M. G., Scaglione, R., Pinto, A. V., & Tuttolomondo, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052445 · Cited by 38
Verapamil and Alzheimer’s Disease: Past, Present, and Future
Popović, N., Morales-Delgado, N., Mena, D. V., Alonso, A., Martínez, M. P., Bleda, M. C., & Popović, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00562 · Cited by 34
Mahinrad, S., Sorond, F. A., & Gorelick, P. B. (2021) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2204148 · Cited by 34
Blood pressure and Alzheimer's disease: A review of meta-analysis
Saiz-Vázquez, O., Puente-Martínez, A., Pacheco, J., & Landa, S. U. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2022.1065335 · Cited by 32
Gavriilaki, M., Anyfanti, P., Mastrogiannis, Κ., Gavriilaki, E., Lazaridis, A. A., Kimiskidis, V. Κ., & Gkaliagkousi, Ε. (2023) · Aging Clinical and Experimental Research · doi:10.1007/s40520-023-02361-7 · Cited by 31
Cognitive impairment in cerebral small vessel disease induced by hypertension
Wei, W., Ma, D., Li, L., & Zhang, L. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385841 · Cited by 37
Huang, W.-Q., Lin, Q., & Tzeng, C. (2024) · Journal of Stroke · doi:10.5853/jos.2023.02719 · Cited by 35
Swartz, R. H., Longman, R. S., Lindsay, M. P., Lund, R., Ganesh, A., Eskes, G. A., Austin, M., Bechard, L., Bhangu, J. S., Bruto, V. C., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14324 · Cited by 35
He, C. Y. Y., Zhou, Z., Kan, M. M. P., Chan, D. H. Y., Wong, A. C. T., Mok, K. H. Y., Lam, F. M. H., Chan, S. C. C., Cheung, C. K. C., Yeung, M. K. C., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102350 · Cited by 36
Population attributable fraction of modifiable risk factors for dementia in Chile
Vergara, R. C., Pedro Zitko, M., Slachevsky, A., Martín, C. S., & Delgado, C. (2022) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12273 · Cited by 33
Nagar, S. D., Pemu, P. I., Qian, J., Boerwinkle, E., Cicek, M. S., Clark, C. R., Cohn, E., Gebo, K. A., Loperena, R., Mayo, K., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-23353-z · Cited by 32
St‐Onge, M., Campbell, A., Aggarwal, B., Taylor, J. L., Spruill, T. M., & RoyChoudhury, A. (2020) · American Heart Journal · doi:10.1016/j.ahj.2020.02.006 · Cited by 30
Özkan, E., Taş, Y. Ç., Şekerdağ, E., Kızılırmak, A. B., Taş, A., Yıldız, E., Eser, H. Y., Karahüseyinoğlu, S., Zeybel, M., & Özdemir, Y. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00767-8 · Cited by 29
Identifying Patients for Intensive Blood Pressure Treatment Based on Cognitive Benefit
Ghazi, L., Shen, J., Ying, J., Derington, C. G., Cohen, J. B., Marcum, Z. A., Herrick, J. S., King, J. B., Cheung, A. K., Williamson, J. D., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.14443 · Cited by 28
Kim, H., Ang, T. F. A., THOMAS, R. J., Lyons, M. J., & Au, R. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13356 · Cited by 26
Niiranen, T., Schnabel, R. B., Schutte, A. E., Biton, Y., Boriani, G., Buckley, C. M., Cameron, A. C., Damasceno, A. A. M., Diederichsen, S. Z., Doehner, W., et al. (2025) · Circulation · doi:10.1161/circulationaha.124.071047 · Cited by 29
Associations Between Brain Volumes and Cognitive Tests with Hypertensive Burden in UK Biobank
Newby, D., Winchester, L. M., Sproviero, W., Fernandes, M., Wang, D., Kormilitzin, A., Launer, L. J., & Nevado‐Holgado, A. J. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210512 · Cited by 28
Hu, Y., Halstead, M., Bryan, R. N., Schreiner, P. J., Jacobs, D. R., Sidney, S. S., Lewis, C. E., & Launer, L. J. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.1175 · Cited by 24
Liu, C., Sung, P., Li, Y., Huang, W., Lee, T.-W., Huang, C., Lee, T., Chen, T., & Wei, Y. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003707 · Cited by 24
Cardiometabolic Trajectories Preceding Dementia in Community-Dwelling Older Individuals
Wu, Z., Cribb, L., Wolfe, R. S., Shah, R. C., Orchard, S. G., Owen, A. J., Woods, R. L., Vishwanath, S., Chong, T. T. ‐., Sheets, K. M., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.58591 · Cited by 21
Mid‐life and late‐life vascular risk factor burden and neuropathology in old age
Conner, S. C., Pase, M. P., Carneiro, H. A., Raman, M. R., McKee, A. C., Alvarez, V. E., Walker, J. M., Satizábal, C. L., Himali, J. J., Stein, T. D., et al. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.50936 · Cited by 21
Self-citationFaria, A. C. R. D. A., Dall'Agnol, J. F., Gouveia, A. M., de Paiva, C. I., Segalla, V. C., & Baena, C. P. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00872-3 · Cited by 25
Zhang, Y., Zhang, P., & Yin, D. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02165-2 · Cited by 20
Hughes, T. M., Lockhart, S. N., Suerken, C. K., Jung, Y., Whitlow, C. T., Bateman, J. R., Williams, B. J., Espeland, M. A., Sachs, B. C., Williamson, J. D., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220646 · Cited by 22
The risk of dementia in multiple sclerosis and neuromyelitis optica spectrum disorder
Cho, E. B., Jung, S. Y., Jung, J., Yeo, Y., Kim, H. J., Han, K., Shin, D. W., & Min, J. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1214652 · Cited by 21
Smith, J. R., Sharrett, A. R., Pike, J. R., Gottesman, R. F., Knopman, D. S., Lee, M., Lutsey, P. L., Palta, P., Windham, B. G., Coresh, J., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12984 · Cited by 19
Contaldi, E., Magistrelli, L., Milner, A. R., Cosentino, M., Marino, F., & Comi, C. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.313061 · Cited by 16
Runk, A., Jia, Y., Liu, A., Chang, C. H., Ganguli, M., & Snitz, B. E. (2021) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617721001363 · Cited by 15
Chen, Y., Liu, Y., Tsai, S., Kuo, P., Huang, S.-S., & Lee, Y. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081124 · Cited by 17
Metadata
- Authors
- McGrath, E. R., Beiser, A. S., DeCarli, C., Plourde, K. L., Vasan, R. S., Greenberg, S. M., & Seshadri, S.
- Affiliations
- Boston University (US)
- From the Department of Neurology (E.R.M.), Brigham & Women's Hospital; Department of Neurology (E.R.M., S.M.G.), Massachusetts General Hospital; Harvard Medical School (E.R.M., S.M.G.); Boston University School of Medicine (A.S.B., R.S.V., S.S.); Boston University School of Public Health (A.S.B., K.L.P., R.S.V.); Framingham Heart Study (A.S.B., R.S.V., S.S.), MA; and 7Department of Neurology (C.D.), University of California, Davis.
- ORCID
- Venue
- Neurology
- Published
- 2017-12-12
- Volume
- 89
- Issue
- 24
- Pages
- 2447-2454
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC5729797
- OpenAlex
- W2767297946
- Cited by
- 289
- References
- 37
- Citations by year
- 2026: 31 · 2025: 40 · 2024: 42 · 2023: 42 · 2022: 44 · 2021: 37 · 2020: 19 · 2019: 22 · 2018: 12
- FWCI
- 11.90
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Neurology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute on Aging (P30AG010129, U01AG049505, U01AG052409, R01AG054076, R01AG049607, R01AG033193)
- National Institute of Neurological Disorders and Stroke (UH2NS100605, R01NS017950)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- blood pressure, dementia, hypertension, midlife, old age, systolic blood pressure, blood pressure reduction, prehypertension, normotension, dementia risk, Framingham Offspring cohort
- MeSH terms
- Adult, Aged, Blood Pressure, Dementia, Female, Humans, Hypertension, Male, Middle Aged, United States, Cohort Studies, Incidence, Multivariate Analysis, Proportional Hazards Models, Prehypertension
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
